Local News
Lilly Ramping Up Production of COVID-19 Therapy
When Indianapolis-based Eli Lilly and Co. (NYSE: LLY) received Emergency Use Authorization from the U.S. Food and Drug Administration for its COVID-19 therapy bamlanivimab, it marked a … [FULL STORY]